Par Pharmaceutical, Inc. v. Twi Pharmaceuticals, Inc.

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

PAR PHARMACEUTICAL, INC., ALKERMES PHARMA IRELAND LIMITED, Plaintiffs-Appellants

v.

TWI PHARMACEUTICALS, INC., Defendant-Appellee ______________________

2015-1880 ______________________

Appeal from the United States District Court for the District of Maryland in No. 1:11-cv-02466-CCB, Judge Catherine C. Blake. ______________________

JUDGMENT ______________________

DANIEL BROWN, Latham & Watkins LLP, New York, NY, argued for plaintiffs-appellants. Plaintiff-appellant Par Pharmaceutical, Inc., also represented by ROGER J. CHIN, GREGORY SOBOLSKI, San Francisco, CA; JONATHAN Y. ELLIS, GREGORY G. GARRE, MICHAEL J. GERARDI, Wash- ington, DC; JAMES PATRICK ULWICK, Kramon and Gra- ham, P.A., Baltimore, MD. MARYELLEN NOREIKA, Morris, Nichols, Arsht & Tun- nell LLP, Wilmington, DE, for plaintiff-appellant Alker- mes Pharma Ireland Limited. Also represented by JACK B. BLUMENFELD, JEREMY A. TIGAN; JAMES PATRICK ULWICK, Kramon and Graham, P.A., Baltimore, MD.

DONALD J. MIZERK, Husch Blackwell LLP, Chicago, IL, argued for defendant-appellee. Also represented by PHILIP DALE SEGREST, JR., JOHN A. SHOLAR, JR. ______________________

THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:

PER CURIAM (O’MALLEY, PLAGER, and WALLACH, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

December 15, 2015 /s/ Daniel E. O’Toole Date Daniel E. O’Toole Clerk of Court